CRP and cellulitis: Notably, several adverse events were observed, including cellulitis at an injection site (N = 1), restenosis (N = 4), chronic subdural hematoma (N =1), bedsores (N = 1), heterotopic ulcer (N = 1), urinary tract infection (N = 1), arthralgia (N = 1), dyspnea (N = 1), hypoperfusion (N = 1), labial herpes simplex (N = 1), diarrhea (N = 1), patellofemoral joint pain (N = 1), fever due to respiratory infection (N = 1), ALP elevation (hepatic–cystic system failure) (N = 1), and CRP elevation (N = 1) [30].